IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition
TORONTO and GLIL YAM, Israel, Jan. 12, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that the final sixth payment of the Oranim Pharmacy Acquisition and the reconciliation between the parties regarding the remaining transaction payments are being rescheduled to April 15, 2024.
Related news for (IMCC)
- IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
- IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
- IM Cannabis Reports Second Quarter 2025 Financial Results
- IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million
- IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3